MEDC.JKMEDC.JK
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.58% | +8.36% | +0.73% | -3.18% | +1638618.67% |
| Gross Profit Growth | -13.09% | -32.86% | -1.45% | -41.35% | +1580721.74% |
| EBITDA Growth | -20.48% | -2.23% | -23.11% | -32.87% | +2425595.90% |
| Operating Income Growth | +43.23% | -12.01% | -17.11% | -47.44% | +867196.16% |
| Net Income Growth | -41.19% | -33.66% | -75.74% | -84.76% | +1096963.73% |
| EPS Growth | -38.30% | -35.09% | -75.86% | -84.62% | +1105762.07% |
| EPS Diluted Growth | -38.30% | -35.09% | -75.86% | -84.62% | +1105762.07% |
| Weighted Average Shares Growth | +0.15% | +0.17% | -0.17% | +0.62% | -1.53% |
| Weighted Average Shares Diluted Growth | +0.15% | +0.18% | -0.17% | -0.15% | -1.53% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -19.95% | +67.10% | -1.45% | -49.97% | +1228210.12% |
| Free Cash Flow Growth | -32.48% | +152.27% | -3.88% | -71.30% | +264339.63% |
| Receivables Growth | +58.73% | +49.17% | +50.36% | +106.68% | +1991499.81% |
| Inventory Growth | +4.90% | +23.16% | +12.93% | +10.90% | +1953001.86% |
| Asset Growth | +12.42% | +6.14% | +6.81% | +7.62% | +1827148.81% |
| Book Value per Share Growth | +13.83% | +15.67% | +10.71% | +4.00% | +1806745.18% |
| Debt Growth | +13.32% | +4.92% | +4.42% | +8.25% | +1848661.10% |
| R&D Expense Growth | +0.00% | +0.00% | -100.00% | -100.00% | +0.00% |
| SG&A Expenses Growth | -1.70% | -38.97% | -11.88% | +8.56% | +6348954.10% |